Picton Mahoney Asset Management’s 2seventy bio TSVT Stock Holding History

Picton Mahoney Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,581	Closed	-$8K	–	1170
2025 Q1	$8K	Buy	+1,581	New	+$5.02K	﹤0.01%	636
2024 Q3	–	Sell	-421	Closed	-$2K	–	963
2024 Q2	$2K	Buy	+421	New	+$1.9K	﹤0.01%	568

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Picton Mahoney Asset Management's TSVT Position: Q2 2025 in Review

Picton Mahoney Asset Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 1,581 shares — an estimated $8K sold.

Picton Mahoney Asset Management first reported a position in TSVT in Q2 2024 and held it in 2 quarters. The position peaked at $8K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Picton Mahoney Asset Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Picton Mahoney Asset Management sold 1,581 2seventy bio shares in Q2 2025, an estimated $8K.
Picton Mahoney Asset Management first reported a position in 2seventy bio in Q2 2024 and held it in 2 quarters.
Picton Mahoney Asset Management's 2seventy bio position peaked at $8K in Q1 2025.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.